Related Experiment Video

Updated: Oct 9, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

Adhesion of adenosine diphosphate-activated platelets to human brain microvascular endothelial cells under flow in

N Tanahashi1, Y Fukuuchi, M Tomita

  • 1Department of Neurology, School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan. tanahasi@med.keio.ac.jp

Neuroscience Letters
|March 10, 2001
PubMed

Insights

TAK-029, a GPIIb/IIIa antagonist, effectively inhibits activated platelet adhesion to human brain microvascular endothelial cells. This suggests GPIIb/IIIa plays a key role in platelet-endothelial cell interactions under flow conditions.

Area of Science:

  • Cardiovascular Biology
  • Neurovascular Research
  • Hematology

Background:

  • Platelet adhesion to endothelial cells is a critical process in vascular health and disease.
  • Understanding the molecular mechanisms of platelet-endothelial cell interactions is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of GPIIb/IIIa in the adhesion of activated platelets to human brain microvascular endothelial cells (HBECs) in vitro.
  • To evaluate the inhibitory effect of TAK-029, a GPIIb/IIIa antagonist, on this adhesion process.

Main Methods:

  • Video-enhanced contrast (VEC) microscopy was used to observe platelet-endothelial cell interactions.
  • Human brain microvascular endothelial cells (HBECs) were cultured and subjected to perfusion with activated platelets under controlled shear rates.
  • The effect of TAK-029 and an anti-GPIbalpha antibody on platelet adhesion was assessed.

Main Results:

  • Activated platelets adhered to HBECs under low shear conditions.
  • TAK-029 significantly suppressed the adhesion of activated platelets to HBECs.
  • An anti-GPIbalpha antibody did not inhibit the adhesion of ADP-activated platelets to HBECs.

Conclusions:

  • Platelet adhesion to HBECs under flow conditions in vitro is primarily mediated by the GPIIb/IIIa receptor.
  • TAK-029 demonstrates potential as an inhibitor of platelet-endothelial cell interactions involving GPIIb/IIIa.

More Related Videos

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...